Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
85 CHF | -1.73% | -1.59% | +0.15% |
07:28am | Novartis reports positive interim results for Fabhalta | CF |
05:26am | Novartis' Investigational Kidney Disease Drug Shows Reduced Disease Marker in Late-stage Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.15% | 207B | |
+28.23% | 676B | |
+24.27% | 559B | |
-7.53% | 356B | |
+15.13% | 320B | |
+5.25% | 286B | |
+2.62% | 213B | |
-9.41% | 199B | |
-7.90% | 142B | |
-3.31% | 116B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- NOVARTIS AG : Goldman Sachs maintains a Buy rating